Atropine therapy has a direct treatment effect on choroidal thickness, which cannot be fully explained by axial length or SER changes.

Age and myopia severity may best determine whether to initiate highly asperhical lenslets or orthokeratology as a myopia control treatment.

Cancer survivors’ use of medical equipment has increased in recent years, and this equipment has the highest proportion of OOP costs, data suggest.